Archive | CERBIOS-PHARMA SA

Page 2 of 4
Cerbios-Pharma showing new manufacturing capabilities at ChemOutsourcing 2019
Cerbios-Pharma showing new manufacturing capabilities at ChemOutsourcing 2019 Learn More >
Cerbios-Pharma brings latest ADC advances to BIO 2019 in Philadelphia
Cerbios-Pharma brings latest ADC advances to BIO 2019 in Philadelphia Learn More >
Cerbios-Pharma announces significant HPAPI and ADC investment
Cerbios-Pharma announces significant HPAPI and ADC investment Learn More >
Cerbios-Pharma Sustainability Report
Cerbios-Pharma Sustainability Report Learn More >
Cerbios-Pharma and PROVEO present payload and conjugation manufacturing services at ADC World London
Cerbios-Pharma and PROVEO present payload and conjugation manufacturing services at ADC World London Learn More >
Cerbios collaborates with IRB on developing targeted leukemia antibodies
Cerbios collaborates with IRB on developing targeted leukemia antibodies Learn More >
US Ambassador visit signals closer American links for Cerbios-Pharma
US Ambassador visit signals closer American links for Cerbios-Pharma Learn More >
Cerbios-Pharma and PROVEO return to World ADC conference with enhanced one-stop offer
Cerbios-Pharma and PROVEO return to World ADC conference with enhanced one-stop offer Learn More >
Cerbios-Pharma Company Brochure
Cerbios-Pharma Company Brochure Learn More >
Cerbios-Pharma showcasing chemical, ADC and biotechnology services at CPhI Worldwide 2018
Cerbios-Pharma showcasing chemical, ADC and biotechnology services at CPhI Worldwide 2018 Learn More >
Cerbios-Pharma brings new generic APIs and ADC technology to BIO Boston
Cerbios-Pharma brings new generic APIs and ADC technology to BIO Boston Learn More >
Cerbios welcomes a comprehensive review on the efficacy and safety of its <i>E. faecium</i> SF68® probiotic
Cerbios welcomes a comprehensive review on the efficacy and safety of its E. faecium SF68® probiotic Learn More >
Page 2 of 4